|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/209 | (2013.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/2031 | (2013.01) | ||
| A61K 31/4725 | (2013.01) | ||
| A61K 31/18 | (2013.01) |
| (11) | Patento numeris | 4255398 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21819877.8 |
| Europos patento paraiškos padavimo data | 2021-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-10-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2021/083654 |
| Data | 2021-11-30 |
| (87) | Numeris | WO 2022/117594 |
| Data | 2022-06-09 |
| (30) | Numeris | Data | Šalis |
| 20211022 | 2020-12-01 | EP |
| (72) |
BOLTROMIUK, Tomasz , PL
|
| (73) |
Adamed Pharma S.A. ,
Pienkow ul. Mariana Adamkiewicza 6A, 05-152 Czosnow,
PL
Adalvo Limited , Malta Life Science Park Building 1 Level 4, San Gwann, SGN 3000, MT |
| (54) | ORALLY-ADMINISTERED PREPARATION CONTAINING SOLIFENACIN AND TAMSULOSIN |
| ORALLY-ADMINISTERED PREPARATION CONTAINING SOLIFENACIN AND TAMSULOSIN |